Please login to the form below

Not currently logged in
Email:
Password:

EvaluatePharma

This page shows the latest EvaluatePharma news and features for those working in and with pharma, biotech and healthcare.

EMA clears BMS’ oral multiple sclerosis drug Zeposia

EMA clears BMS’ oral multiple sclerosis drug Zeposia

EvaluatePharma estimates drug could earn $1.6bn in 2024. Bristol-Myers Squibb now has a green light for its oral, once-daily multiple sclerosis therapy Zeposia on both sides of the ... Zeposia is one of the drugs that was highlighted by BMS as the driver

Latest news

More from news
Approximately 3 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • It started with a miss It started with a miss

    The stakes are high and getting higher. A recent report from EvaluatePharma forecasts that pharma is on the brink of a second patent cliff, with worldwide drug sales of over $198bn

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    EvaluatePharma has predicted it could become a nearly $2.5bn product by 2024, providing it can also pick up approvals in AML and other indications like multiple myeloma.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    EvaluatePharma forecasts that Lynparza (now co-marketed with Merck &Co) will hit annual revenues of $2.2bn by 2024, with Imfinzi expected to reach $3.65bn and Tagrisso leading the way

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The company is currently the pharma industry’s biggest player by revenue (earning $45.4bn in 2017), but analysts EvaluatePharma expect Novartis to overtake it by 2024.

  • Deal Watch May 2016 Deal Watch May 2016

    A recent analysis through 2015 made by EvaluatePharma shows that six of the top ten pharma companies will derive less than 20% of drug sales from products that were developed from

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics